Trump’s watered down drug pricing rule saves 96% less than initial proposal

RegulatoryNegative

AI Analysis

Summary

The Trump administration finalized a drug pricing rule for Medicare that applies to only four companies and delivers 96% less savings than the initial proposal. The rule targets drugs administered in physician offices.

Outcome Details

Final drug pricing rule published affecting four companies; significantly reduced savings compared to initial proposal

Importance:6/10

Sentiment:

-0.60

drug pricingMedicareregulatoryTrump administrationphysician-administered drugs

Related Companies

$GBCMD

Read the original article

Published by STAT News on September 30, 2026 11:15 PM

Read Original